Literature DB >> 6265356

Broadly active inhibitor of viruses spontaneously produced by many cell types in culture.

S Baron, L McKerlie.   

Abstract

A broadly active inhibitor of viruses (vaccinia, polio 1, and vesicular stomatitis) was found in the culture fluid from many types of normal human and mouse cells in culture. Virus plaque-inhibiting activity appeared in culture fluids within a few hour after incubation of cultures with fresh medium. Peak inhibitory activity occurred within 24 h. Blockade of cellular ribonucleic acid or protein synthesis decreased appearance of the inhibitor, thereby substantiating that it is a cell-produced viral inhibitor. Inhibition of virus required the simultaneous presence of inhibitor, virus, and cells (due to the reversible nature of the inhibition of virus attachment and penetration, as shown in the accompanying paper [T. K. Hughes et al., Infect Immun. 32:454-457, 1981]). The degree of inhibitory activity depended on the animal species of origin of the inhibitor, the cell type used for assay, and the virus type used for challenge. No cell species barrier against inhibitor action was found. Strong inhibition of multicycle yields of vesicular stomatitis virus and Sindbis virus was caused by low doses of inhibitor. These specific characteristics of the present inhibitor separate it from commonly recognized inhibitors. Possible biological significance of the inhibitor is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265356      PMCID: PMC351464          DOI: 10.1128/iai.32.2.449-453.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  A microplaque reduction assay for human and mouse interferon.

Authors:  J B Campbell; T Grunberger; M A Kochman; S L White
Journal:  Can J Microbiol       Date:  1975-08       Impact factor: 2.419

Review 2.  Serum inhibitors of myxoviruses.

Authors:  O Krizanová; V Rathová
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

3.  Antiviral activity in milk of possible clinical importance.

Authors:  T H Matthews; C D Nair; M K Lawrence; D A Tyrrell
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  Cell-produced viral inhibitor: possible mechanism of action and chemical composition.

Authors:  T K Hughes; J E Blalock; M L McKerlie; S Baron
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  General considerations of the interferon system.

Authors:  S Baron; F Dianzani
Journal:  Tex Rep Biol Med       Date:  1977

6.  Antiviral action of mouse interferon in heterologous cells.

Authors:  C E Buckler; S Baron
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

7.  The mammalian cell-virus relationship. II. Adsorption, reception, and eclipse of poliovirus by HeLa cells.

Authors:  J J HOLLAND; L C McLAREN
Journal:  J Exp Med       Date:  1959-05-01       Impact factor: 14.307

  7 in total
  10 in total

1.  Interferon induction with polyinosinic:polycytidylic acid in the newborn piglet.

Authors:  K G Loewen; J B Derbyshire
Journal:  Can J Vet Res       Date:  1986-04       Impact factor: 1.310

2.  An influenza virus inhibitor that acts late in the replication cycle.

Authors:  G Antonelli; F Dianzani; D H Coppenhaver; S Baron; P Calandra; G Folchitto
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

3.  Fetal rhesus monkey lung cells can be grown in serum-free medium for the replication of dengue-2 vaccine virus.

Authors:  B Malewicz; L E Anderson; K Crilly; H M Jenkin
Journal:  In Vitro Cell Dev Biol       Date:  1985-08

4.  Cell-produced viral inhibitor: possible mechanism of action and chemical composition.

Authors:  T K Hughes; J E Blalock; M L McKerlie; S Baron
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  Size and stability of a naturally occurring virus inhibitor.

Authors:  D H Coppenhaver; J L Baron; M L McKerlie; J Sabados; S Baron
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

6.  Transcriptional control of the bovine leukemia virus genome: role and characterization of a non-immunoglobulin plasma protein from bovine leukemia virus-infected cattle.

Authors:  P Gupta; S V Kashmiri; J F Ferrer
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

7.  Innate gastrointestinal immunity: characterization of broadly active viral inhibitors.

Authors:  I P Singh; D H Coppenhaver; A K Chopra; S Baron
Journal:  Antiviral Res       Date:  2001-03       Impact factor: 5.970

Review 8.  Innate antiviral defenses in body fluids and tissues.

Authors:  S Baron; I Singh; A Chopra; D Coppenhaver; J Pan
Journal:  Antiviral Res       Date:  2000-11       Impact factor: 5.970

Review 9.  Innate defences against viraemia.

Authors:  I P Singh; S Baron
Journal:  Rev Med Virol       Date:  2000 Nov-Dec       Impact factor: 6.989

Review 10.  Recently described innate broad spectrum virus inhibitors.

Authors:  S Baron; D Niesel; I P Singh; L McKerlie; J Poast; A Chopra; G Antonelli; F Dianzani; D H Coppenhaver
Journal:  Microb Pathog       Date:  1989-10       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.